| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99499 |
|
8,066 |
6,120 |
$2.25M |
| 0450 |
Emergency room services |
18,509 |
16,588 |
$1.33M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,235 |
10,834 |
$896K |
| 0762 |
|
440 |
420 |
$702K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
7,191 |
6,516 |
$508K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,455 |
1,348 |
$388K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,618 |
2,450 |
$381K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,195 |
1,142 |
$276K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
8,748 |
8,012 |
$258K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,567 |
3,840 |
$212K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,006 |
1,865 |
$196K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,377 |
1,271 |
$194K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
22,537 |
20,085 |
$188K |
| 80053 |
Comprehensive metabolic panel |
12,759 |
11,652 |
$174K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
823 |
809 |
$129K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,571 |
1,431 |
$99K |
| 0710 |
|
940 |
879 |
$99K |
| J3490 |
Unclassified drugs |
27,248 |
10,490 |
$99K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,122 |
1,101 |
$96K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
591 |
572 |
$82K |
| 71045 |
Radiologic examination, chest; single view |
5,430 |
5,010 |
$77K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,250 |
1,969 |
$74K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,294 |
1,867 |
$72K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,581 |
1,529 |
$66K |
| Z7502 |
|
1,710 |
1,673 |
$62K |
| A4217 |
Sterile water/saline, 500 ml |
4,515 |
3,854 |
$60K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,949 |
2,646 |
$52K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
539 |
489 |
$48K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
5,461 |
4,652 |
$47K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,423 |
4,639 |
$44K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,574 |
2,555 |
$43K |
| 0270 |
|
2,730 |
2,114 |
$35K |
| 0272 |
|
1,413 |
1,269 |
$30K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,961 |
3,223 |
$29K |
| 84484 |
|
3,322 |
2,857 |
$29K |
| 83690 |
|
3,639 |
3,219 |
$27K |
| 0360 |
|
350 |
227 |
$27K |
| 99199 |
Unlisted special service, procedure or report |
403 |
358 |
$26K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
338 |
302 |
$25K |
| 96379 |
|
1,433 |
1,074 |
$24K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
13 |
13 |
$23K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,186 |
1,952 |
$20K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
75 |
75 |
$20K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
324 |
311 |
$17K |
| 83880 |
|
658 |
603 |
$13K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
398 |
396 |
$11K |
| 83735 |
|
1,986 |
1,612 |
$11K |
| 71046 |
Radiologic examination, chest; 2 views |
407 |
383 |
$10K |
| J2704 |
Injection, propofol, 10 mg |
904 |
721 |
$9K |
| 0259 |
|
1,658 |
1,031 |
$8K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,380 |
1,318 |
$8K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,707 |
1,565 |
$8K |
| 83605 |
|
956 |
839 |
$8K |
| 81001 |
|
2,472 |
2,315 |
$8K |
| J2060 |
Injection, lorazepam, 2 mg |
878 |
787 |
$8K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
912 |
875 |
$7K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
606 |
543 |
$7K |
| 0250 |
|
282 |
234 |
$7K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
318 |
253 |
$6K |
| 36415 |
Collection of venous blood by venipuncture |
3,717 |
2,635 |
$6K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
27 |
26 |
$6K |
| 70496 |
|
24 |
24 |
$6K |
| 70498 |
|
25 |
25 |
$6K |
| 80306 |
|
190 |
179 |
$5K |
| 73562 |
|
147 |
139 |
$5K |
| 85610 |
|
1,891 |
1,730 |
$5K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
146 |
67 |
$5K |
| 84703 |
|
717 |
662 |
$5K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
490 |
434 |
$4K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
297 |
150 |
$4K |
| 85730 |
|
994 |
926 |
$4K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
91 |
90 |
$3K |
| Z7610 |
|
302 |
231 |
$3K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
376 |
322 |
$3K |
| 73030 |
|
82 |
78 |
$3K |
| G0378 |
Hospital observation service, per hour |
14 |
12 |
$3K |
| 81003 |
|
654 |
633 |
$3K |
| 93971 |
|
27 |
25 |
$2K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
12 |
12 |
$2K |
| 87040 |
|
187 |
159 |
$2K |
| 0750 |
|
14 |
14 |
$2K |
| 70486 |
|
12 |
12 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
134 |
118 |
$2K |
| J1644 |
Injection, heparin sodium, per 1000 units |
217 |
160 |
$2K |
| 71250 |
|
12 |
12 |
$2K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
151 |
108 |
$2K |
| 76641 |
|
28 |
28 |
$2K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
79 |
77 |
$2K |
| 85379 |
|
168 |
163 |
$2K |
| 86900 |
|
215 |
198 |
$2K |
| 77066 |
Tomosynthesis, mammo |
12 |
12 |
$2K |
| 73610 |
|
44 |
41 |
$1K |
| 86850 |
|
100 |
93 |
$1K |
| 86901 |
|
203 |
186 |
$1K |
| 0370 |
|
28 |
28 |
$925.60 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
116 |
66 |
$858.63 |
| 72100 |
|
26 |
26 |
$800.80 |
| 86140 |
|
142 |
140 |
$791.02 |
| V2632 |
Posterior chamber intraocular lens |
40 |
40 |
$768.01 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
16 |
16 |
$758.94 |
| 88304 |
|
65 |
65 |
$745.49 |
| 71010 |
|
42 |
24 |
$743.82 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
71 |
66 |
$707.00 |
| 81025 |
|
56 |
56 |
$706.33 |
| 71020 |
|
23 |
12 |
$685.56 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
164 |
62 |
$652.14 |
| 87186 |
|
98 |
97 |
$628.04 |
| 73630 |
|
15 |
14 |
$618.81 |
| 87077 |
|
130 |
129 |
$603.20 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
12 |
12 |
$559.35 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
43 |
43 |
$506.35 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
12 |
12 |
$452.14 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
14 |
13 |
$451.43 |
| C1769 |
Guide wire |
28 |
26 |
$424.02 |
| 73130 |
|
12 |
12 |
$391.03 |
| 84145 |
|
14 |
14 |
$330.41 |
| 99070 |
|
170 |
78 |
$304.86 |
| 84443 |
Thyroid stimulating hormone (TSH) |
19 |
15 |
$206.82 |
| 85652 |
|
65 |
65 |
$175.14 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
45 |
44 |
$129.89 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
32 |
30 |
$54.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
48 |
40 |
$51.59 |
| 87205 |
|
16 |
13 |
$45.68 |
| 80061 |
Lipid panel |
12 |
12 |
$0.00 |
| 0258 |
|
15 |
15 |
$0.00 |